ArticleInternational journal of molecular sciences2018

Development of Biomarkers for Inhibition of SLC6A19 (B⁰AT1)-A Potential Target to Treat Metabolic Disorders.

Kiran Javed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.